This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cmc Icos Biologics, Inc.. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Friday Harbor, WA (US) (2015 - 2016)
- Mukliteo, WA (US) (2018)
Company Filing History:
Years Active: 2015-2018
Title: Howard R. Clarke: Innovator in Recombinant Protein Expression
Introduction
Howard R. Clarke is a notable inventor based in Friday Harbor, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein expression. With a total of 3 patents, Clarke's work has advanced the methods used for producing recombinant proteins, which are essential in various medical and industrial applications.
Latest Patents
One of Clarke's latest patents focuses on recombinant protein expression using a hybrid CHEF1 promoter. This invention provides expression vectors and host cells designed for high-level expression of recombinant proteins. The expression vectors incorporate Chinese hamster ovary elongation factor 1-α (CHEF1) transcriptional regulatory DNA elements along with a cytomegalovirus (CMV) promoter and/or a human adenovirus tripartite leader (AdTPL) sequence. This innovative approach achieves increased protein expression and enhances the productivity of host cells compared to previously described expression systems.
Career Highlights
Clarke is currently associated with CMC Icos Biologics, Inc., where he continues to develop and refine techniques for protein expression. His expertise in this area has positioned him as a key figure in the biotechnology sector, contributing to advancements that have far-reaching implications in medicine and research.
Conclusion
Howard R. Clarke's work in recombinant protein expression exemplifies the impact of innovation in biotechnology. His patents reflect a commitment to improving the efficiency and effectiveness of protein production, which is vital for various applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile